VIGIL NEUROSCIENCE INC. - COMMON STOCK
3.1900
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.1900
+6.33%
Today's range
2.9800 - 3.2500
ISIN
N/A
Source
NASDAQ
-
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
12 Mar 2024 06:05:00 By Nasdaq GlobeNewswire
-
06 Mar 2024 15:25:47 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference
07 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
03 Jan 2024 15:30:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference
22 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Third Quarter 2023 Financial Results and Provides Business Update
07 Nov 2023 06:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
05 Oct 2023 15:01:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 06:05:00 By Nasdaq GlobeNewswire
-
11 Sep 2023 11:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Announces Update on its Small Molecule TREM2 Agonist Program
08 Sep 2023 15:05:38 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2023 Morgan Stanley Global Healthcare Conference
08 Sep 2023 06:05:56 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports Second Quarter 2023 Financial Results and Provides Business Update
08 Aug 2023 06:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Appoints Christopher J. Silber, M.D. as Chief Medical Officer
07 Aug 2023 15:05:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience to Present at 2023 Jefferies Global Healthcare Conference
01 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Reports First Quarter 2023 Financial Results and Provides Business Update
10 May 2023 06:00:00 By Nasdaq GlobeNewswire
-
Vigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D. to Board of Directors
09 May 2023 06:00:02 By Nasdaq GlobeNewswire